Sharing innovative features: a Tool For non inVaSiVe aSSeSSmenT new and qUanTiFicaTion oF STeaToSiS cap™ is a measure of the ultrasound attenuation which corresponds to the decrease in amplitude of ultrasound waves as they propagate through the liver. cap™ is powered by a sophisticated guidance process based on VcTe™ that ensures that: → cap™ and liver stiffness are simultaneously measured in the same liver volume → cap™ is calculated only if liver stiffness measurement is valid → gain (ultrasound amplitude) → Ultrasound frequency Are controlled And predefined → region of measurement → cap™ is measured with the m probe at 3.5 mhz at depth between 25 and 65 mm → cap™ is expressed in decibel per meter (dB/m) CAP™ measurement like for liver stiffness measurement with the FibroScan502 Touch,® cap™ measurement: → isnon invasive → is immediate: does not lengthen the FibroScan examination® → benefits from an established examination procedure: the final cap™ result is the median of at least 10 valid cap™ measurements → can be performed by an operator without any ultrasound imaging skills CaP™ is a tool for non invasive assessment and quantification of steatosis enhancing the spectrum of non invasive methods for the examination and follow-up of patients with liver disease.